United States: Oregon Prescription Drug Price Transparency Act In Limbo - Sheppard Mullin Richter & Hampton

On February 16, the U. S. District Court for the District of Oregon struck down the state's drug price transparency law—The Prescription Drug Price Transparency Act (the "Act"...